Amount raised
$58M
Round
Series A
Date raised
October 6, 2026
Founded
—
CompanyRouge Therapeutics
IndustryBiotechnology
InvestorsBioGeneration Ventures, Angelini Ventures, Kurma Partners
Websitewww.rougetx.com
Founders
- Professor Franck LebrinCo-founder
- Jérémy ThalgottCo-founder
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Rouge Therapeutics
a provider of first-in-class disease-modifying therapies designed to restore vascular integrity
- How much did Rouge Therapeutics raise?
- Rouge Therapeutics raised $58M in a Series A round on October 6, 2026. Investors include BioGeneration Ventures, Angelini Ventures, Kurma Partners.
- Who founded Rouge Therapeutics?
- Professor Franck Lebrin and Jérémy Thalgott co-founded Rouge Therapeutics.